☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
NICE Recommendation
Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma
October 19, 2021
Novartis's Adakveo (crizanlizumab) Receives NICE Recommendation as a New Therapy for Sickle Cell Disease
October 6, 2021
BioCryst's Orladeyo (berotralstat) Receives NICE Recommendation as First Oral Therapy to Prevent HAE Attacks in the UK
September 16, 2021
UCB's Bimekizumab Receives NICE Recommendation for the Fast-Track Appraisal to Treat Severe Plaque Psoriasis
August 3, 2021
Load more...
Back to Home